(Date:11/20/2008)...v. 20 ReachMD, the first satellite...by medical professionals, announced,today their n...merican Medical,Directors Association (AMDA), the...ttending physicians, and others practicing in the ... Crecelius, President of AMDA says, "ReachMD provi...
(Date:11/20/2008)... Nov. 10 Precision Therapeutics In...g response tests, has secured $43 million,in addi...rcialization of,ChemoFx(R). ChemoFx is a diagnos...fective chemotherapeutic regimen for cancer patien...P., led the round and was joined by existing,inve...
(Date:11/20/2008)...t cancer patients who underwent a mastectomy who u...construction, autologous tissue reconstruction pro...metic results than tissue expander and implant rec...issue of the International Journal of Radiation O...the American Society for Therapeutic Radiology and...
(Date:11/20/2008)...of the brain chemical serotonin may be key, study ...ws) -- Variations in the genetic makeup of alcohol...ggests. , And the key might be the brain,s cont...chemical. , The research could potentially help...f becoming an alcoholic, and then treat that perso...
Breaking Medicine News(10 mins):Health News:ReachMD Announces New Strategic Partnership with American Medical Directors Association 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3Health News:Type of breast reconstruction impacts radiation therapy outcomes 2Health News:Genetic Trait Linked to Alcoholism 2(Date:11/19/2008)... N.Y., Nov. 19 Biotech scientists ... toxicology research to better understand the effe... systems, reports Genetic Engineering & Biote...sted in figuring out a new compound,s mechanism of...icology technique, according to the November 15 is...
(Date:11/18/2008)...ber 19 NeuroDiscovery Lt...ovider and drug development Company,and Sosei Gr..., a leading,international biopharmaceutical compa...ing further pivotal pre-clinical efficacy data for...tential therapy for neuropathic pain and has,succ...
(Date:11/18/2008)...., Nov. 18 Forty-two le... a November national forum to consider cutting-edg...lth and national economy from outbreaks of dangero...day. , , Among those innovations: , , ...an kitchen table that detects highly contagious an...
(Date:11/13/2008)...Mass., Nov. 13 Hologic, ...cturer and supplier of premium,diagnostics, medica...to,serving the healthcare needs of women, today an...pivotal clinical trial. The Cervista HPV high-risk...U.S. and is expected to be,launched in the Europea...
Breaking Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4Fires Put Pregnant Women Infants at Risk 4423 1Fires Put Pregnant Women Infants at Risk 4423 2Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 1Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 2Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 3Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 4Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 1Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 2Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 3Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 1Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 2Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 3Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 4...April 11 /CNW/ - Liponex Inc. (TSX:LPX), a,biophar...nced,products related to High Density Lipoprotein ...unced information from further,analysis of the Pha...CRD5 is being developed for the treatment of dysli...patient information indicated that all,blood chemi...
...N FRANCISCO, Calif., April 13, 2007,/PRNewswire-Fi...nounced that the company will present data at the ...cer Research (AACR) being held,April 14-18, 2007 i...in a poster session will focus on,non-clinical dat...tor of cyclin-dependent kinases (CDKs) 2, 7 and 9 ...
Other Medicine Technology:Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 2Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 3Sunesis Pharmaceuticals to Present Data at the Annual Meeting of,the American Association for Cancer Research 2...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: